(688016)"Shanghai Microport Endovascular Medtech (Group) Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688016 · · 13 pages · Chinese
Summary by 6ix AI
The report includes information on revenue, total profit, and net profit attributable to shareholders, along with changes compared to the previous year. The document emphasizes the accuracy and completeness of the financial information provided by the company's board and management.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai MicroPort Endovascular MedTech Co., Ltd on 6ix
Earlier from Shanghai MicroPort Endovascular MedTech
- (688016)"Shanghai Microport Endovascular Medtech (Group) Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Medical Device and Medical Equipment Industry
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Resolutions of the 2025 Annual General Meeting
- Report for Q1 2026
Follow Shanghai MicroPort Endovascular MedTech into a list and get an email when it puts out news.
Follow Shanghai MicroPort Endovascular MedTech